Millennium Nutrient N,N-Dimethylglycine (DMG) and its Effectiveness in Autism Spectrum Disorders.

Dimethylglycine autism spectrum disorders (ASD) central nervous system (CNS) complementary and alternative medicine (CAM) neurological disorders pharmacology

Journal

Current medicinal chemistry
ISSN: 1875-533X
Titre abrégé: Curr Med Chem
Pays: United Arab Emirates
ID NLM: 9440157

Informations de publication

Date de publication:
2022
Historique:
received: 11 04 2021
revised: 09 10 2021
accepted: 11 10 2021
pubmed: 27 11 2021
medline: 24 5 2022
entrez: 26 11 2021
Statut: ppublish

Résumé

Autism is a neurodevelopmental disorder belonging to the autism spectrum disorder (ASD). In ASDs, the individuals show substantial impairments in social communication, repetitive behaviours, and sensory behaviours deficits in the early stages of their life. Globally, the prevalence of autism is estimated to be less than 1%, especially in high- -income countries. In recent decades, there has been a drastic increase in the incidence of ASD, which has put ASD into the category of epidemics. Presently, two US Food and Drug Administration-approved drugs, aripiprazole and risperidone, are used to treat symptoms of agitation and irritability in autistic children. However, to date, no medication has been found to treat the core symptoms of ASD. The adverse side effects of conventional medicine and limited treatment options have led families of autistic children to turn to complementary and alternative medicine (CAM) treatments, which are perceived as relatively safe compared to conventional medicine. Recently N, N-dimethylglycine (DMG), a dietary supplement, has emerged as a useful supplement to improve the mental and physical state of children with ASD. The current review discusses ASD, the prevalence of ASD, the CAM approach, and the efficacy of CAM treatment in children with ASD. Moreover, it highlights the chemistry, pharmacological effect, and clinical studies of DMG, highlighting its potential for improving the lifestyle of children with ASD.

Identifiants

pubmed: 34823458
pii: CMC-EPUB-119050
doi: 10.2174/0929867328666211125091811
doi:

Substances chimiques

dimethylglycine 7797M4CPPA
Sarcosine Z711V88R5F

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2632-2651

Subventions

Organisme : University Hospital Hradec Kralove, UHK PrF project
ID : VT2019-2021
Organisme : PERSONMED—Center for the Development of Personalized Medicine in Age-Related Diseases
ID : CZ.02.1.01/0.0/0.0/17_048/0007441

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Daljeet Singh Dhanjal (DS)

Department of Biotechnology, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, India.

Sonali Bhardwaj (S)

Department of Microbiology, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, India.

Chirag Chopra (C)

Department of Molecular Biology and Genetic Engineering, School of Bioengineering and Biosciences, Lovely Professional University, India.

Reena Singh (R)

Department of Biotechnology, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, India.

Jiri Patocka (J)

Department of Radiology, Toxicology and Populati on Protecti on, Faculty of Health and Social Studies, the University of South Bohemia in Ceske Budejovice, Czech Republic.
University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.

Bohumir Plucar (B)

Reflex Therapy Laboratory, Udolni 393/18, 60200 Brno, Czech Republic.

Eugenie Nepovimova (E)

Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic.

Martin Valis (M)

University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.

Kamil Kuca (K)

University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH